Casanova-Acebes, María http://orcid.org/0000-0002-5790-1163
Dalla, Erica
Leader, Andrew M.
LeBerichel, Jessica
Nikolic, Jovan
Morales, Blanca M.
Brown, Markus
Chang, Christie http://orcid.org/0000-0002-7651-7220
Troncoso, Leanna
Chen, Steven T.
Sastre-Perona, Ana
Park, Matthew D.
Tabachnikova, Alexandra
Dhainaut, Maxime
Hamon, Pauline
Maier, Barbara
Sawai, Catherine M.
Agulló-Pascual, Esperanza
Schober, Markus
Brown, Brian D. http://orcid.org/0000-0002-3670-8778
Reizis, Boris http://orcid.org/0000-0003-1140-7853
Marron, Thomas
Kenigsberg, Ephraim http://orcid.org/0000-0002-4107-3295
Moussion, Christine http://orcid.org/0000-0002-1641-4094
Benaroch, Philippe
Aguirre-Ghiso, Julio A. http://orcid.org/0000-0002-6694-6507
Merad, Miriam http://orcid.org/0000-0002-4481-7827
Article History
Received: 1 March 2020
Accepted: 18 May 2021
First Online: 16 June 2021
Competing interests
: J.A.A.-G. is a scientific co-founder of, scientific advisory board member and equity owner in HiberCell and receives financial compensation as a consultant for HiberCell, a Mount Sinai spin-off company focused on therapeutics that prevent or delay cancer recurrence. M.M. serves on the scientific advisory boards of Compugen Inc., Innate Pharma Inc., Morphic Therapeutic, Myeloid Therapeutics, Celsius Therapeutics and Genenta. M.M. receives funding from Genentech Inc., Regeneron Inc., Boerhinger Ingelheim Inc. and Takeda Inc. M.M. has ownership interest of less than 5% in Compugen Inc., Celsius Therapeutics Inc., Dren Bio Inc., and Asher Bio Inc. B.M.M., M.B. and C.M. declare that they are Genentech/Roche employees.